Institutional Collaboration Across Stakeholders, fostering shared governance and aligned incentives among payers, providers, and life sciences partners.

The Hidden Problem With ‘Vibe Coding’ Apps on Apple’s App Store Your email has been sent Software developers have been using AI to assist with coding ever since the introduction of generative AI. In ...

Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped ...

Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early-stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most ...

Apple has quietly blocked AI "vibe coding" apps, such as Replit and Vibecode, from releasing App Store updates unless they make changes, The Information reports. "Vibe coding" tools allow users with ...

AI is making app development easier than ever. However, a new report claims Apple’s App Store isn’t fully embracing these new tools. Companies behind two “vibe coding” apps that let you create tools ...

A new study from researchers at the Alliance for Clinical Trials in Oncology (Alliance) shows that patients with stage III ...

The Centers for Medicare & Medicaid Services March 20 released a memorandum reinforcing hospital nutrition service ...

Picture this: You’ve got a great idea. Maybe it’s an app, a tool, or a game. There’s just one problem: You’re not a developer. The gap between idea and execution used to be vast, requiring thousands ...

Prevalence of High-Risk Human Papillomavirus and Associated Risk Factors Among Individuals With Head and Neck Cancer in a National Referral Center in Tanzania The retrospective study included 83 ...

A small red berry grown in South Florida is helping cancer patients reclaim something many lose during treatment: the ability to enjoy food. Known scientifically as Synsepalum dulcificum, the fruit is ...

Coherus Oncology (NASDAQ:CHRS) executives said the company has moved quickly through a multi-year transformation toward becoming an “innovative oncology company,” highlighting a sharply improved ...